JAZZ PHARMACEUTICALS
Jazz Pharmaceuticals is a specialty pharmaceutical company that identifies develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. Jazz Pharmaceuticals focuses on identifying, developing, and commercializing products for neurology and psychiatry primarily in the United States. Its products include Xyrem for the treatment of cataplexy and excessive daytime sleepiness in patients with narcolepsy; Cystadane for the treatment of homocystinuri... a, an inherited metabolic disease; and Antizol to treat ethylene glycol and methanol poisoning. Its late-stage product candidates comprise Luvox CR, an extended-release formulation of fluvoxamine, a selective serotonin reuptake inhibitor, which is used for the treatment of obsessive-compulsive disorder and social anxiety disorder; and JZP-6, a liquid dosage form of sodium oxybate in Xyrem, for the treatment of fibromyalgia syndrome.
JAZZ PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2003-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.jazzpharma.com
Total Employee:
501+
Status:
Active
Contact:
6504962651
Email Addresses:
[email protected]
Total Funding:
1.96 B USD
Technology used in webpage:
LetsEncrypt Apache Wordpress Plugins Global Site Tag IPv6 JQuery CDN Hubspot Wordfence TablePress Wistia
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
CANbridge Pharmaceuticals
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-02-03 | GW Pharmaceuticals | GW Pharmaceuticals acquired by Jazz Pharmaceuticals | 7.2 B USD |
| 2019-08-13 | Cavion | Cavion acquired by Jazz Pharmaceuticals | 321.5 M USD |
| 2019-07-10 | Redx Pharma | Redx Pharma acquired by Jazz Pharmaceuticals | N/A |
| 2016-05-31 | Celator Pharmaceuticals | Celator Pharmaceuticals acquired by Jazz Pharmaceuticals | 1.5 B USD |
| 2016-05-11 | Amolyt Pharma | Amolyt Pharma acquired by Jazz Pharmaceuticals | 20.5 M USD |
| 2013-12-19 | Gentium | Gentium acquired by Jazz Pharmaceuticals | N/A |
| 2012-04-26 | EUSA Pharma | EUSA Pharma acquired by Jazz Pharmaceuticals | 650 M USD |
| 2011-09-19 | Azur Pharma | Azur Pharma acquired by Jazz Pharmaceuticals | N/A |
| 2005-04-19 | Orphan Medical | Orphan Medical acquired by Jazz Pharmaceuticals | 122.6 M USD |
Investors List
Longitude Capital
Longitude Capital investment in Post-IPO Equity - Jazz Pharmaceuticals
Kingsbridge Capital
Kingsbridge Capital investment in Post-IPO Equity - Jazz Pharmaceuticals
Thoma Cressey Equity Partners
Thoma Cressey Equity Partners investment in Series B - Jazz Pharmaceuticals
Lehman Brothers
Lehman Brothers investment in Series B - Jazz Pharmaceuticals
Adams Street Partners
Adams Street Partners investment in Series B - Jazz Pharmaceuticals
Beecken Petty O'Keefe & Company
Beecken Petty O'Keefe & Company investment in Series B - Jazz Pharmaceuticals
EGS Healthcare Capital Partners
EGS Healthcare Capital Partners investment in Series B - Jazz Pharmaceuticals
Prospect Venture Partners
Prospect Venture Partners investment in Series B - Jazz Pharmaceuticals
Golden Gate Capital
Golden Gate Capital investment in Series B - Jazz Pharmaceuticals
Versant Ventures
Versant Ventures investment in Series B - Jazz Pharmaceuticals
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-07-29 | Onera Health | Jazz Pharmaceuticals investment in Series B - Onera Health | 10.5 M EUR |
| 2019-04-24 | Onera Health | Jazz Pharmaceuticals investment in Series A - Onera Health | 8.16 M EUR |
| 2019-04-23 | Onera | Jazz Pharmaceuticals investment in Series A - Onera | 9.3 M USD |
| 2016-05-25 | Arrivo BioVentures LLC | Jazz Pharmaceuticals investment in Series A - Arrivo BioVentures LLC | 49 M USD |
Official Site Inspections
http://www.jazzpharma.com Semrush global rank: 497.81 K Semrush visits lastest month: 100.19 K
- Host name: ec2-44-224-64-152.us-west-2.compute.amazonaws.com
- IP address: 44.224.64.152
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818
More informations about "Jazz Pharmaceuticals"
About | Jazz Pharmaceuticals
You are now leaving www.JazzPharma.com. Thank you for visiting. The information on the website you are entering is intended for visitors in the United States only. Ok Cancel. …See details»
Our Purpose - Jazz Pharmaceuticals
Organization: Address Line 1: ... Thank you for visiting JazzPharma.com. The site you are about to visit is maintained by a third party who is solely responsible for its content; Jazz …See details»
Careers Home | Jazz Pharmaceuticals Careers
We are deeply committed to living our purpose, values and being a high-performance organization. We pride ourselves in being a great place to work. Each career we build reflects …See details»
Jazz Pharmaceuticals - Wikipedia
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is a global biopharmaceutical company with a focus on oncology and neuroscience.It was founded …See details»
Who We Are | Jazz Pharmaceuticals Careers
Community Engagement Building bridges. Giving back. At Jazz Pharmaceuticals, community engagement is a fundamental aspect of our mission. We recognize that fostering meaningful connections with the communities we serve is crucial …See details»
Jazz Pharmaceuticals - Crunchbase Company Profile
Contact Email [email protected] Phone Number 6504962651 Jazz Pharmaceuticals is a specialty pharmaceutical company that identifies develops and commercializes innovative treatments for important, underserved markets …See details»
Jazz Pharmaceuticals Announces CEO Succession Plan
Dec 16, 2024 [email protected] Ireland +353 1 634 3211 U.S. +1 650 496 2717. Media: Kristin Bhavnani Head of Global Corporate Communications Jazz Pharmaceuticals plc …See details»
Research and Development | Jazz Pharmaceuticals Careers
At Jazz Pharmaceuticals, our Research & Development (R&D) Organization is a vibrant hub of innovation and growth. With an unwavering commitment to developing life-changing …See details»
Jazz Pharmaceuticals
Mar 16, 2025 Jazz Pharmaceuticals was founded in 2003 as a specialty biopharmaceutical company. Since then, we have grown rapidly, extending our specialty focus to include adult …See details»
Canada - Jazz Pharmaceuticals
Jazz Pharmaceuticals Canada. Jazz Pharmaceuticals Canada, Inc. 4080 Confederation Parkway Suite 602 Mississauga, Ontario L5B 0G1 Main Line: 647-946-8801See details»
Jazz Pharmaceuticals Announces CEO Succession Plan - Yahoo …
Dec 16, 2024 Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Bruce Cozadd, Co-Founder, Chairperson and Chief Executive Officer (CEO), has informed the Board of …See details»
Corporate | Jazz Pharmaceuticals Careers
At Jazz Pharmaceuticals, our Corporate Team operates at a global level, ensuring smooth operations across our diverse footprint. Our employees work collaboratively to analyze and …See details»
Investors - Jazz Pharmaceuticals plc
[email protected] Ireland: +353 1 634 3211 U.S.: +1 650 496 2717 . Investors News Releases March 5, 2025 Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying …See details»
Wellthy for Jazz Pharmaceuticals
Wellthy provides hands-on, 1:1 support from experts who help families navigate their unique care needs across every phase of life and during life's most vital moments.See details»
Jazz Pharmaceuticals Announces CEO Succession Plan
Dec 16, 2024 Media: Kristin Bhavnani Head of Global Corporate Communications Jazz Pharmaceuticals plc [email protected] +353 1 637 …See details»
Zanidatamab Granted Priority Review for HER2-Positive Metastatic ...
May 29, 2024 [email protected] Ireland +353 1 637 2141 U.S. +1 215 867 4948. Jazz Investor Contact: Andrea N. Flynn, Ph.D. Vice President, Head, Investor …See details»
California jobs | Jazz Pharmaceuticals Careers
Brief Description: The Associate Director, Marketing Operations Center will lead the team responsible for the operationalization of best-in-class capabilities and infrastructure to execute …See details»
Jazz Pharmaceuticals Announces CEO Succession Plan
Dec 16, 2024 [email protected] Ireland +353 1 634 3211 U.S. +1 650 496 2717. Media: Kristin Bhavnani Head of Global Corporate Communications Jazz Pharmaceuticals plc …See details»
History - Jazz Pharmaceuticals
Organization: Address Line 1: ... Thank you for visiting JazzPharma.com. The site you are about to visit is maintained by a third party who is solely responsible for its content; Jazz …See details»
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying …
Mar 5, 2025 Copies of the documents filed with the SEC by Jazz will be available free of charge on Jazz's website at https://investor.jazzpharma.com or by contacting Jazz's Investor …See details»